Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nanoform logo — Nanoform uses platform technologies to develop innovative na...

Nanoform

Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical attrition and enhancing drug performance.

Founded 2015 Finland Finland Grant Total: $46.30M Biotechnology, Pharmaceutical

General Information

Company Name Nanoform
Founded Year 2015
Location Finland Finland +1
Founders / Decision Makers
Team member
Industries Biotechnology, Pharmaceutical
Funding Stage Grant
Social

Get notified when Nanoform moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nanoform

Nanoform is a pioneering enterprise founded in 2015, specializing in manufacturing nanoparticle-based medicines with the aim of revolutionizing the drug development industry. The company's slogan "Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical attrition and enhancing drug performance" encapsulates its core mission. Nanoform collaborates with pharmaceutical and biotechnology partners worldwide to develop cutting-edge medications and offer new possibilities for patients. The company's advanced platform technologies are utilized to optimize drug molecules' effectiveness and diminish clinical attrition rates. Its services include GMP manufacturing, formulation assistance, and solutions for drug solubility, bioavailability, and innovative drug delivery systems. Nanoform's last investment of €4.30M, a grant investment at 15 February 2024, was secured from Business Finland. Operating from Finland, Nanoform is poised to make significant contributions to the biotechnology and pharmaceutical industries.

Taxonomy: nanoparticle medicines, drug development, pharmaceutical, nanotechnology, drug delivery systems, GMP manufacturing, formulation assistance, bioavailability, clinical development, drug solubility, platform technologies, innovation, clinical attrition

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
15 Feb 2024
Post-IPO Equity •••••• - 22 Mar 2022
Venture Round •••••• 2
Investor Investor
02 Jul 2019
Corporate Round •••••• - 21 Sep 2018

Nanoform Alternatives & Competitors

Nanoform vs
Ardena
Ardena Belgium

Navigating you through drug development

466 employees
Health Care, Pharmaceutical
Nanoform vs
Nanoform
Nanoform Finland

Global experts in nanotechnology and drug particle engineering

161 employees
Nanoform vs
Quris AI
Quris AI United States

Leading the AI-Pharma Revolution

Seed
35 employees
AI, Biotechnology
Compare Nanoform vs Quris AI

FAQ About Nanoform

Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical attrition and enhancing drug performance.
Nanoform was founded in 2015.
Nanoform is headquartered in Finland.
Nanoform operates in the following industries: Biotechnology, Pharmaceutical.
Nanoform has completed 4 funding rounds, raising a total of $46.30M. The latest funding stage is Grant.
Top alternatives and competitors to Nanoform include Ardena, Nanoform, Quris AI, Byondis, Nitto Avecia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanoform and Ardena are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nanoform and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy